The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
IRAK4 (gene symbol: IRAK4, UniProt accession: Q9NWZ3) encodes interleukin-1 receptor-associated kinase 4, a catalytically active serine/threonine kinase (EC 2.7.11.1) that serves as a central component of innate immune signaling in humans (najjar2024interleukin1receptorassociatedkinase pages 1-2, pereira2023regulationofinnate pages 1-2). The protein is ubiquitously expressed in human tissues, distinguishing it from IRAK3/IRAK-M, which is primarily induced in monocytes and macrophages (najjar2024interleukin1receptorassociatedkinase pages 1-2). IRAK4 belongs to the protein kinase superfamily, specifically the TKL (tyrosine kinase-like) Ser/Thr protein kinase family, and contains key domains including a death domain-like superfamily domain, consistent with the UniProt annotation provided (pereira2023regulationofinnate pages 1-2, pereira2023regulationofinnate pages 2-4).
IRAK4 possesses a modular domain architecture comprising three principal regions that are critical for its dual functions in innate immunity. The N-terminal death domain (DD) mediates homotypic death-domain interactions with the adaptor protein MyD88 and enables recruitment into the supramolecular signaling complex known as the Myddosome (srikanth2024irak4autophosphorylationcontrols pages 4-6, pereira2023regulationofinnate pages 2-4). This death domain is essential for initial complex assembly and occurs independently of IRAK4's catalytic activity, as demonstrated by experiments showing that death-domain-only constructs or kinase-inactive IRAK4 can still co-assemble with MyD88 (srikanth2024irak4autophosphorylationcontrols pages 4-6).
The central proline/serine/threonine-rich (ProST) region connects the death domain to the kinase domain and serves as a regulatory linker that is itself subject to autophosphorylation (pereira2023regulationofinnate pages 1-2, luo2025anexaminationof pages 4-7). The C-terminal kinase domain provides the enzymatic activity necessary for substrate phosphorylation. Importantly, unlike IRAK1, IRAK2, and IRAK3, IRAK4 lacks an extended C-terminal domain containing TRAF6-binding motifs, positioning it primarily as an upstream activating kinase rather than a direct TRAF6-recruiting scaffold (pereira2023regulationofinnate pages 2-4, suresh2026phosphoregulationofinterleukin1 pages 2-3).
IRAK4 functions as an ATP-dependent serine/threonine kinase whose activation is intimately coupled to its assembly within the Myddosome complex. The catalytic mechanism involves trans-autophosphorylation, wherein MyD88-mediated oligomerization brings IRAK4 kinase domains into proximity, enabling one IRAK4 molecule to phosphorylate another (srikanth2024irak4autophosphorylationcontrols pages 4-6, srikanth2024irak4autophosphorylationcontrols pages 1-4). Autophosphorylation occurs at Thr345/Ser346 and represents a discrete, energy-dependent activation step that follows initial death-domain-mediated recruitment but precedes stable IRAK1 incorporation (srikanth2024irak4autophosphorylationcontrols pages 1-4, srikanth2024irak4autophosphorylationcontrols pages 4-6).
Recent mechanistic studies have established that IRAK4 autophosphorylation functions as a molecular switch converting initial MyD88-IRAK4 assemblies into mature, signaling-competent Myddosomes (srikanth2024irak4autophosphorylationcontrols pages 4-6, srikanth2024irak4autophosphorylationcontrols pages 6-8). This autophosphorylation is not required for initial complex formation but is essential for recruitment and oligomerization of downstream IRAK family members (srikanth2024irak4autophosphorylationcontrols pages 1-4, srikanth2024irak4autophosphorylationcontrols pages 6-8). Pharmacological inhibition or genetic ablation of IRAK4 kinase activity blocks this maturation step while preserving the initial structural assembly, demonstrating the separability of scaffold and catalytic functions (srikanth2024irak4autophosphorylationcontrols pages 4-6, srikanth2024irak4autophosphorylationcontrols pages 6-8).
The primary physiological substrate of IRAK4 is IRAK1, with the most well-characterized phosphorylation event occurring at IRAK1 threonine 209 (Thr209) (suresh2026phosphoregulationofinterleukin1 pages 3-5, suresh2026phosphoregulationofinterleukin1 pages 2-3). This initiating phosphorylation induces a conformational change in IRAK1 that enables subsequent phosphorylation at threonine 387 (Thr387) within the activation loop, releasing IRAK1 from its autoinhibited conformation and promoting full catalytic activity (suresh2026phosphoregulationofinterleukin1 pages 3-5). While Thr387 is commonly described in the IRAK4-to-IRAK1 activation sequence, some evidence suggests this later event may involve IRAK1 autophosphorylation rather than direct IRAK4-mediated phosphorylation (suresh2026phosphoregulationofinterleukin1 pages 3-5).
IRAK4 also phosphorylates and activates IRAK2, although the specific phosphorylation sites and mechanistic details remain less precisely defined than for IRAK1 (suresh2026phosphoregulationofinterleukin1 pages 2-3, pereira2022theirak4scaffold pages 1-3, suresh2026phosphoregulationofinterleukin1 pages 1-2). The substrate specificity of IRAK4 is determined primarily by proximity and orientation within the Myddosome rather than by a simple linear sequence motif, reflecting the importance of the supramolecular assembly in constraining and directing kinase activity (pereira2023regulationofinnate pages 1-2, srikanth2024irak4autophosphorylationcontrols pages 4-6).
IRAK4 carries out its primary functions at the cytoplasmic face of activated plasma membrane receptors, where it is recruited into receptor-proximal Myddosome complexes (pereira2023regulationofinnate pages 2-4, suresh2026phosphoregulationofinterleukin1 pages 3-5, pereira2022theirak4scaffold pages 1-3). Following activation of IL-1 family receptors or most Toll-like receptors (TLRs), the adaptor protein MyD88 oligomerizes and recruits IRAK4 through death domain interactions (pereira2023regulationofinnate pages 2-4). IRAK4 is not a transmembrane, extracellular, or constitutively nuclear protein; rather, it functions specifically at sites of activated innate immune receptor signaling (pereira2023regulationofinnate pages 2-4, pereira2023regulationofinnate pages 1-2).
Endosomal TLRs, particularly TLR7 and TLR9, also recruit IRAK4 into cytoplasmic signalosomes following receptor engagement (pereira2023regulationofinnate pages 1-2, pereira2022theirak4scaffold pages 3-5). The kinase activity of IRAK4 is particularly critical for TLR7-associated inflammatory responses, as kinase-deficient macrophages show severe impairment in cytokine production after TLR7 stimulation (pereira2022theirak4scaffold pages 5-6, pereira2022theirak4scaffold pages 3-5).
Recent studies have identified a noncanonical, MyD88-independent pathway in which IRAK4 functions in the cytoplasm following DNA double-strand breaks induced by ionizing radiation (li2023anoncanonicalirak4irak1 pages 3-4, li2023anoncanonicalirak4irak1 pages 4-6). In this pathway, IRAK4 is activated in the cytoplasm as early as 5-15 minutes after irradiation, forms complexes with IRAK1 independently of MyD88, and phosphorylates IRAK1 at Thr209 (li2023anoncanonicalirak4irak1 pages 3-4, li2023anoncanonicalirak4irak1 pages 4-6). Activated IRAK1 then translocates to the nucleus where it exerts anti-apoptotic effects, demonstrating that IRAK4 can function in DNA damage responses beyond its canonical role in pathogen recognition (li2023anoncanonicalirak4irak1 pages 3-4, li2023anoncanonicalirak4irak1 pages 4-6).
IRAK4 occupies a pivotal position in the MyD88-dependent signaling cascade linking innate immune receptors to inflammatory transcriptional responses. The canonical pathway proceeds as follows: receptor activation → MyD88 recruitment and oligomerization → IRAK4 recruitment and trans-autophosphorylation → IRAK1/2 phosphorylation and activation → TRAF6 recruitment and K63-linked ubiquitination → TAK1-TAB2/3 complex activation → parallel activation of IKK and MAPK cascades (suresh2026phosphoregulationofinterleukin1 pages 3-5).
IRAK4 primarily controls the NF-κB branch of TLR signaling (suresh2026phosphoregulationofinterleukin1 pages 3-5). Following TRAF6 activation, the IKK complex phosphorylates IκB proteins, leading to their ubiquitin-dependent proteasomal degradation and enabling NF-κB dimers (predominantly RelA/p65 and c-Rel) to translocate to the nucleus and drive expression of pro-inflammatory cytokines including TNF-α, IL-6, and IL-12, as well as chemokines and adhesion molecules (suresh2026phosphoregulationofinterleukin1 pages 3-5, pereira2022theirak4scaffold pages 1-3, pereira2022theirak4scaffold pages 3-5).
In parallel to NF-κB activation, IRAK4-initiated signaling activates mitogen-activated protein kinase (MAPK) cascades through the TAK1 complex (suresh2026phosphoregulationofinterleukin1 pages 3-5, pereira2023regulationofinnate pages 1-2). TAK1 phosphorylates and activates the MKK3/6-p38, MKK4/7-JNK, and MEK1/2-ERK cascades, which in turn drive AP-1-dependent transcription and regulate cytokine mRNA stability and translation (suresh2026phosphoregulationofinterleukin1 pages 3-5, pereira2022theirak4scaffold pages 3-5). The quantitative dependence of MAPK activation on IRAK4 kinase activity varies by receptor type and cellular context, with some compensation possible through IRAK1 and IRAK2 in specific settings (pereira2022theirak4scaffold pages 3-5, pereira2023regulationofinnate pages 7-8).
A critical feature of IRAK4 biology is its dual functionality as both a catalytic kinase and a structural scaffold protein. These functions are biochemically and genetically separable, as demonstrated by extensive studies using kinase-dead mutants, knockout cells, and pharmacological inhibitors (pereira2022theirak4scaffold pages 1-3, pereira2022theirak4scaffold pages 3-5, pereira2023regulationofinnate pages 7-8).
The kinase function is essential for MyD88-dependent signaling: IRAK4 catalytic activity is required for phosphorylation of IRAK1 and IRAK2, enabling their downstream signaling activities (pereira2022theirak4scaffold pages 1-3, pereira2022theirak4scaffold pages 5-6, pereira2022theirak4scaffold pages 3-5). This is particularly evident for TLR7 signaling, where kinase-deficient IRAK4 cells show profound defects in cytokine production and NF-κB activation (pereira2022theirak4scaffold pages 5-6, pereira2022theirak4scaffold pages 6-8). The kinase activity also promotes IRAK1 degradation, thereby contributing to both signal initiation and termination (pereira2023regulationofinnate pages 7-8).
The scaffold function is kinase-independent and supports the assembly and integration of signaling complexes (pereira2023regulationofinnate pages 7-8, pereira2022theirak4scaffold pages 5-6). Kinase-inactive IRAK4 can still recruit into Myddosomes and bind IRAK1/2, though these complexes are functionally defective (pereira2022theirak4scaffold pages 5-6). The scaffold role is particularly important in TLR4 signaling, where IRAK4 serves as an integration point for both the MyD88 and TRIF pathways at the level of TRAF6 activation (pereira2022theirak4scaffold pages 1-3, pereira2022theirak4scaffold pages 6-8, pereira2022theirak4scaffold pages 10-11). Complete IRAK4 loss eliminates both kinase and scaffold functions and produces more severe phenotypes than kinase inhibition alone, explaining why IRAK4 degraders may have broader therapeutic effects than catalytic inhibitors (pereira2023regulationofinnate pages 7-8, pereira2022theirak4scaffold pages 8-10).
TLR4 is unique among TLRs in signaling through both MyD88-dependent and TRIF-dependent pathways. IRAK4's scaffold function enables integration of these pathways at TRAF6, coordinating their convergence on NF-κB and MAPK activation (pereira2022theirak4scaffold pages 1-3, pereira2022theirak4scaffold pages 3-5, pereira2022theirak4scaffold pages 10-11). The IRAK4 scaffold supports TRIF-dependent TRAF6, NF-κB, and p38/ERK activation independently of its catalytic activity, while the TRIF-TRAF3-IRF3 branch leading to type I interferon production remains comparatively IRAK4-independent (pereira2022theirak4scaffold pages 6-8, pereira2022theirak4scaffold pages 10-11).
Beyond NF-κB and AP-1, IRAK4-dependent signaling contributes to activation of interferon regulatory factors (IRFs), particularly IRF5 and IRF7 (pereira2023regulationofinnate pages 1-2, pereira2023regulationofinnate pages 7-8). In plasmacytoid dendritic cells stimulated through TLR7/9, MyD88-IRAK signaling activates IRF7, driving type I interferon production (suresh2026phosphoregulationofinterleukin1 pages 3-5, pereira2023regulationofinnate pages 7-8). These distal IRF outputs are mediated substantially through downstream IRAK1 rather than direct IRAK4 phosphorylation of the transcription factors (pereira2023regulationofinnate pages 7-8).
The functional characterization of IRAK4 rests on extensive experimental evidence from multiple complementary approaches. Genetic studies using kinase-inactive knock-in mice (Irak4^Ki) have demonstrated that IRAK4 catalytic activity is essential for most MyD88-dependent TLR responses while TLR4 shows partial preservation due to compensatory IRAK1 recruitment and TRIF-mediated signaling (pereira2022theirak4scaffold pages 5-6, pereira2022theirak4scaffold pages 3-5, pereira2022theirak4scaffold pages 6-8). Complete IRAK4-deficient cells (Irak4^-/-) show more profound defects, including abolished MAPK activation and severely impaired bacterial clearance (pereira2022theirak4scaffold pages 6-8, pereira2022theirak4scaffold pages 8-10).
Pharmacological studies using selective IRAK4 kinase inhibitors, particularly PF-06650833, have confirmed the kinase-dependent nature of MyD88 signaling while revealing the kinase-independent scaffold function (pereira2022theirak4scaffold pages 5-6, srikanth2024irak4autophosphorylationcontrols pages 4-6, val2025humanirakkinases pages 7-9). Reconstitution experiments in triple-knockout cells have shown that wild-type IRAK4 restores signaling while kinase-dead mutants or death-domain-only constructs cannot, despite forming initial complexes with MyD88 (srikanth2024irak4autophosphorylationcontrols pages 4-6, srikanth2024irak4autophosphorylationcontrols pages 6-8).
Biochemical assays have directly demonstrated IRAK4 autophosphorylation and IRAK1 phosphorylation, with trans-autophosphorylation detected by phospho-specific antibodies recognizing Thr345/Ser346 and downstream IRAK1 Thr209 phosphorylation (srikanth2024irak4autophosphorylationcontrols pages 1-4, srikanth2024irak4autophosphorylationcontrols pages 4-6). Time-course studies have established the sequence of events: MyD88 oligomerization → IRAK4 recruitment (unphosphorylated) → IRAK4 autophosphorylation → IRAK1 recruitment and phosphorylation → downstream signaling (srikanth2024irak4autophosphorylationcontrols pages 4-6, srikanth2024irak4autophosphorylationcontrols pages 1-4, srikanth2024irak4autophosphorylationcontrols pages 6-8).
Recent literature from 2023-2025 highlights IRAK4 as an important therapeutic target for inflammatory diseases and cancer. The heterobifunctional degrader KT-474 (SAR444656) has shown promising results in phase 1 clinical trials for hidradenitis suppurativa and atopic dermatitis, achieving >95% IRAK4 degradation in blood at therapeutic doses and demonstrating improvement in skin lesions and inflammatory biomarkers (najjar2024interleukin1receptorassociatedkinase pages 1-2). Other IRAK4 inhibitors including zabedosertib and emavusertib are in clinical development for various inflammatory conditions and hematologic malignancies (pereira2023regulationofinnate pages 1-2).
The dual kinase-scaffold function of IRAK4 has important implications for therapeutic strategy: degraders that eliminate the protein may be more effective than kinase inhibitors alone, particularly for conditions where the scaffold function contributes to pathology (pereira2023regulationofinnate pages 7-8). However, the relative importance of kinase versus scaffold functions varies by disease context and receptor pathway, suggesting that therapeutic approaches may need to be tailored to specific clinical indications (pereira2023regulationofinnate pages 6-7, pereira2023regulationofinnate pages 7-8).
| Category | IRAK4 property | Functional interpretation and evidence | Key citations |
|---|---|---|---|
| Identity | Human IRAK4, a catalytically active serine/threonine kinase | Interleukin-1 receptor-associated kinase 4 is an early signal transducer in MyD88-dependent innate immunity and is distinct from IRAK1, IRAK2, and IRAK3/IRAK-M. | (najjar2024interleukin1receptorassociatedkinase pages 1-2, pereira2023regulationofinnate pages 1-2) |
| Domain architecture | N-terminal death domain (DD) | Mediates homotypic death-domain interactions with MyD88 and other IRAKs, recruiting IRAK4 into the Myddosome. DD-only or kinase-inactive IRAK4 can enter initial MyD88 assemblies, showing that recruitment is structurally separable from catalysis. | (srikanth2024irak4autophosphorylationcontrols pages 4-6, pereira2023regulationofinnate pages 2-4) |
| Domain architecture | Proline/serine/threonine-rich linker (ProST region) | Connects the death and kinase domains and provides a regulatory, phosphorylation-rich region. Its exact IRAK4-specific mechanistic contribution remains less firmly resolved than those of the DD and kinase domain. | (pereira2023regulationofinnate pages 1-2, luo2025anexaminationof pages 4-7, suresh2026phosphoregulationofinterleukin1 pages 2-3) |
| Domain architecture | C-terminal kinase domain | Binds ATP and transfers phosphate to serine/threonine residues. Myddosome-driven proximity promotes IRAK4 trans-autophosphorylation, after which the kinase domain supports IRAK1/2 recruitment or activation and productive inflammatory signaling. | (srikanth2024irak4autophosphorylationcontrols pages 4-6, srikanth2024irak4autophosphorylationcontrols pages 1-4) |
| Domain architecture | Absence of the extended C-terminal TRAF6-binding region found in IRAK1/2 | IRAK4 primarily recruits MyD88 and initiates IRAK activation; downstream IRAK1/2 proteins provide C-terminal TRAF6-binding functions. This distinguishes IRAK4 from other IRAK-family architectures. | (pereira2023regulationofinnate pages 2-4, suresh2026phosphoregulationofinterleukin1 pages 2-3) |
| Enzymatic reaction | ATP-dependent protein serine/threonine phosphorylation | IRAK4 catalyzes transfer of the ATP γ-phosphate to hydroxyl groups on protein serine or threonine residues. Physiological specificity is strongly imposed by proximity and orientation within the Myddosome rather than by a broad, fully defined linear sequence motif. | (pereira2023regulationofinnate pages 1-2, srikanth2024irak4autophosphorylationcontrols pages 4-6, suresh2026phosphoregulationofinterleukin1 pages 3-5) |
| Substrate | IRAK4 itself: Thr345/Ser346-associated autophosphorylation | MyD88-dependent clustering brings IRAK4 kinase domains together for trans-autophosphorylation. This occurs after IRAK4 recruitment but before stable IRAK1 incorporation and acts as an energy-dependent Myddosome-maturation switch. | (srikanth2024irak4autophosphorylationcontrols pages 1-4, srikanth2024irak4autophosphorylationcontrols pages 4-6) |
| Substrate | IRAK1: Thr209 | The best-supported direct IRAK4 target in canonical and DNA-damage-associated signaling. Thr209 phosphorylation initiates IRAK1 conformational activation and enables later activation-loop phosphorylation and autophosphorylation. | (suresh2026phosphoregulationofinterleukin1 pages 3-5, li2023anoncanonicalirak4irak1 pages 4-6) |
| Substrate | IRAK1: Thr387 | Commonly placed in the hierarchical IRAK4-to-IRAK1 activation sequence, but some accounts assign the later Thr387 event partly or wholly to activated IRAK1 autophosphorylation. It should therefore not be treated as an unequivocal direct IRAK4 site without assay-specific qualification. | (suresh2026phosphoregulationofinterleukin1 pages 3-5) |
| Substrate | IRAK2 | IRAK4-dependent phosphorylation promotes IRAK2 activation, although the relevant human phosphorylation sites and whether all are direct remain less precisely established than for IRAK1 Thr209. | (suresh2026phosphoregulationofinterleukin1 pages 2-3, pereira2022theirak4scaffold pages 1-3, suresh2026phosphoregulationofinterleukin1 pages 1-2) |
| Canonical localization | Cytoplasmic face of activated plasma-membrane receptors | Following activation of IL-1-family receptors or cell-surface TLRs, MyD88 recruits IRAK4 into receptor-proximal Myddosomes; IRAK4 is not a transmembrane, extracellular, or constitutively nuclear protein. | (pereira2023regulationofinnate pages 2-4, suresh2026phosphoregulationofinterleukin1 pages 3-5, pereira2022theirak4scaffold pages 1-3) |
| Canonical localization | Endosomal receptor-associated Myddosomes | Endosomal MyD88-dependent TLRs, especially TLR7 and TLR9, also recruit IRAK4 into cytoplasmic signalosomes. IRAK4 kinase activity is particularly important for TLR7-associated inflammatory signaling. | (pereira2023regulationofinnate pages 1-2, pereira2022theirak4scaffold pages 3-5, pereira2022theirak4scaffold pages 5-6) |
| Noncanonical localization | Cytoplasmic IRAK4–IRAK1 complex after DNA double-strand breaks | Ionizing radiation activates IRAK4 in the cytoplasm independently of MyD88 and canonical TLR/IL-1R engagement. IRAK4 phosphorylates IRAK1, after which activated IRAK1 translocates to the nucleus and supports cell survival. | (li2023anoncanonicalirak4irak1 pages 3-4, li2023anoncanonicalirak4irak1 pages 4-6) |
| Upstream pathway | IL-1-family receptors | IL-1β and related IL-1-family inputs recruit MyD88 through receptor TIR domains, initiating the MyD88 → IRAK4 → IRAK1/2 signaling hierarchy. | (suresh2026phosphoregulationofinterleukin1 pages 3-5, pereira2023regulationofinnate pages 1-2) |
| Upstream pathway | Most Toll-like receptors, but not TLR3 | Cell-surface and endosomal TLRs that use MyD88 recruit IRAK4. TLR3 signals through TRIF without the canonical MyD88–IRAK4 Myddosome, whereas TLR4 uses both MyD88 and TRIF branches. | (pereira2023regulationofinnate pages 2-4, pereira2022theirak4scaffold pages 18-19) |
| Core signaling sequence | Receptor → MyD88 → IRAK4 → IRAK1/2 → TRAF6 | IRAK4 occupies the MyD88-proximal Myddosome layer, undergoes trans-autophosphorylation, and activates downstream IRAKs. IRAK1/2 then engage TRAF6 and promote nondegradative ubiquitin signaling. | (suresh2026phosphoregulationofinterleukin1 pages 3-5, pereira2023regulationofinnate pages 2-4) |
| NF-κB branch | TRAF6 → TAK1–TAB2/3 → IKK → IκB degradation → NF-κB | K63-linked ubiquitin scaffolds recruit TAK1 complexes; IKK activation causes IκB phosphorylation and degradation, permitting RelA/p65 and c-Rel nuclear entry and inflammatory-gene transcription. | (suresh2026phosphoregulationofinterleukin1 pages 3-5, pereira2022theirak4scaffold pages 3-5, pereira2022theirak4scaffold pages 6-8) |
| MAPK branch | TAK1 → p38, JNK, and ERK cascades → AP-1 | IRAK4-initiated IRAK–TRAF6 signaling activates MAPK cascades that regulate AP-1-dependent transcription and cytokine-mRNA responses. The quantitative dependence on IRAK4 kinase activity varies by receptor and cell type. | (suresh2026phosphoregulationofinterleukin1 pages 3-5, pereira2023regulationofinnate pages 1-2, pereira2022theirak4scaffold pages 3-5) |
| IRF outputs | IRF5 and IRF7-associated responses | MyD88–IRAK signaling can activate IRF5 and, in plasmacytoid dendritic cells stimulated through TLR7/9, IRF7 and type-I-interferon production. These distal outputs are mediated substantially through downstream IRAK1 rather than direct IRAK4 phosphorylation of the IRFs. | (pereira2023regulationofinnate pages 1-2, suresh2026phosphoregulationofinterleukin1 pages 3-5, pereira2023regulationofinnate pages 7-8) |
| Catalytic function | Phosphorylation-dependent maturation of the Myddosome | IRAK4 kinase activity is dispensable for initial MyD88–IRAK4 coassembly but required for autophosphorylation, efficient IRAK1 incorporation, downstream IRAK modification, and robust IL-1R or MyD88-only TLR signaling. | (srikanth2024irak4autophosphorylationcontrols pages 4-6, srikanth2024irak4autophosphorylationcontrols pages 6-8) |
| Scaffold function | Noncatalytic assembly and stabilization of signaling complexes | Kinase-inactive IRAK4 can still recruit into the Myddosome and bind IRAK1/2. Complete IRAK4 loss is consequently more disruptive than catalytic inhibition because it removes both enzymatic and structural functions. | (pereira2023regulationofinnate pages 7-8, pereira2022theirak4scaffold pages 5-6) |
| TLR4-specific scaffold role | Integration of MyD88 and TRIF signals at TRAF6 | In TLR4 signaling, the IRAK4 scaffold supports TRIF-dependent TRAF6, NF-κB, and MAPK activation independently of IRAK4 catalysis, while the TRIF–TRAF3–IRF3 branch remains comparatively IRAK4 independent. | (pereira2022theirak4scaffold pages 1-3, pereira2022theirak4scaffold pages 6-8, pereira2022theirak4scaffold pages 10-11) |
| Functional evidence | Kinase-dead mutants, knockout cells, reconstitution, and selective inhibition | Kinase-inactive IRAK4 or PF-06650833 suppresses IRAK phosphorylation, NF-κB signaling, and cytokine production—especially after TLR7 stimulation—while IRAK4-null cells show broader defects that expose the protein’s additional scaffold role. | (pereira2022theirak4scaffold pages 5-6, pereira2022theirak4scaffold pages 6-8, srikanth2024irak4autophosphorylationcontrols pages 4-6) |
| Functional summary | Proximity-activated kinase and receptor-proximal scaffold | IRAK4 converts ligand-induced MyD88 oligomerization into a phosphorylation- and ubiquitin-dependent inflammatory relay. Its principal precise role is to assemble and mature the Myddosome and activate IRAK1/2, not to directly phosphorylate distal NF-κB or MAPK components. | (pereira2022theirak4scaffold pages 1-3, srikanth2024irak4autophosphorylationcontrols pages 4-6, suresh2026phosphoregulationofinterleukin1 pages 3-5) |
Table: This table integrates IRAK4 domain architecture, catalytic substrates, cellular sites of action, pathway position, and separable kinase-versus-scaffold functions. It also distinguishes well-supported direct phosphorylation events from mechanistic assignments that remain qualified or context dependent.
IRAK4 is a ubiquitously expressed serine/threonine kinase that serves as a central hub in innate immune signaling. Its primary molecular function is to act as a proximity-activated kinase that phosphorylates IRAK1 (at Thr209) and IRAK2, thereby initiating the downstream signaling cascade leading to NF-κB and MAPK activation. IRAK4 carries out these functions within cytoplasmic receptor-proximal Myddosome complexes assembled at activated TLR and IL-1 family receptors. The protein possesses separable kinase and scaffold functions, with the kinase activity being particularly important for MyD88-dependent signaling and the scaffold function enabling integration of MyD88 and TRIF pathways at TRAF6 in TLR4 signaling. The substrate specificity of IRAK4 is determined primarily by proximity within the supramolecular Myddosome assembly rather than by simple linear sequence motifs, and its activation involves trans-autophosphorylation that serves as an energy-dependent maturation switch converting initial protein assemblies into signaling-competent complexes. These findings, derived from extensive genetic, biochemical, and pharmacological studies published primarily between 2022-2026, establish IRAK4 as a critical node in innate immunity and an important therapeutic target for inflammatory diseases.
References
(najjar2024interleukin1receptorassociatedkinase pages 1-2): Mariana K. Najjar, Munazza S. Khan, Chuling Zhuang, Ankush Chandra, and Hui-Wen Lo. Interleukin-1 receptor-associated kinase 1 in cancer metastasis and therapeutic resistance: mechanistic insights and translational advances. Cells, 13:1690, Oct 2024. URL: https://doi.org/10.3390/cells13201690, doi:10.3390/cells13201690. This article has 14 citations.
(pereira2023regulationofinnate pages 1-2): Milton Pereira and Ricardo T. Gazzinelli. Regulation of innate immune signaling by irak proteins. Frontiers in Immunology, Feb 2023. URL: https://doi.org/10.3389/fimmu.2023.1133354, doi:10.3389/fimmu.2023.1133354. This article has 164 citations and is from a peer-reviewed journal.
(pereira2023regulationofinnate pages 2-4): Milton Pereira and Ricardo T. Gazzinelli. Regulation of innate immune signaling by irak proteins. Frontiers in Immunology, Feb 2023. URL: https://doi.org/10.3389/fimmu.2023.1133354, doi:10.3389/fimmu.2023.1133354. This article has 164 citations and is from a peer-reviewed journal.
(srikanth2024irak4autophosphorylationcontrols pages 4-6): Niranjan Srikanth, Rafael Deliz-Aguirre, Deepika Kumari Gola, Margaux Bilay, Elke Ziska, and Marcus J. Taylor. Irak4 autophosphorylation controls inflammatory signaling by activating irak oligomerization. bioRxiv, Feb 2024. URL: https://doi.org/10.1101/2023.12.21.572799, doi:10.1101/2023.12.21.572799. This article has 2 citations.
(luo2025anexaminationof pages 4-7): Ruiqin Luo, Yuexin Yao, Zhuo Chen, and Xiaoming Sun. An examination of the lps-tlr4 immune response through the analysis of molecular structures and protein–protein interactions. Cell Communication and Signaling : CCS, Mar 2025. URL: https://doi.org/10.1186/s12964-025-02149-4, doi:10.1186/s12964-025-02149-4. This article has 219 citations.
(suresh2026phosphoregulationofinterleukin1 pages 2-3): Manasa Suresh, Chrysilla Espy Vaz, Leona Dcunha, Rajesh Raju, Sneha M. Pinto, and Saptami Kanekar. Phosphoregulation of interleukin-1 receptor-associated kinase 1 in inflammatory signaling. Sep 2026. URL: https://doi.org/10.3389/fimmu.2026.1937314, doi:10.3389/fimmu.2026.1937314. This article has 0 citations and is from a peer-reviewed journal.
(srikanth2024irak4autophosphorylationcontrols pages 1-4): Niranjan Srikanth, Rafael Deliz-Aguirre, Deepika Kumari Gola, Margaux Bilay, Elke Ziska, and Marcus J. Taylor. Irak4 autophosphorylation controls inflammatory signaling by activating irak oligomerization. bioRxiv, Feb 2024. URL: https://doi.org/10.1101/2023.12.21.572799, doi:10.1101/2023.12.21.572799. This article has 2 citations.
(srikanth2024irak4autophosphorylationcontrols pages 6-8): Niranjan Srikanth, Rafael Deliz-Aguirre, Deepika Kumari Gola, Margaux Bilay, Elke Ziska, and Marcus J. Taylor. Irak4 autophosphorylation controls inflammatory signaling by activating irak oligomerization. bioRxiv, Feb 2024. URL: https://doi.org/10.1101/2023.12.21.572799, doi:10.1101/2023.12.21.572799. This article has 2 citations.
(suresh2026phosphoregulationofinterleukin1 pages 3-5): Manasa Suresh, Chrysilla Espy Vaz, Leona Dcunha, Rajesh Raju, Sneha M. Pinto, and Saptami Kanekar. Phosphoregulation of interleukin-1 receptor-associated kinase 1 in inflammatory signaling. Sep 2026. URL: https://doi.org/10.3389/fimmu.2026.1937314, doi:10.3389/fimmu.2026.1937314. This article has 0 citations and is from a peer-reviewed journal.
(pereira2022theirak4scaffold pages 1-3): Milton Pereira, Danielle F Durso, Clare E Bryant, Evelyn A Kurt-Jones, Neal Silverman, Douglas T Golenbock, and Ricardo T Gazzinelli. The irak4 scaffold integrates tlr4-driven trif and myd88 signaling pathways. Cell reports, 40:111225-111225, Aug 2022. URL: https://doi.org/10.1016/j.celrep.2022.111225, doi:10.1016/j.celrep.2022.111225. This article has 141 citations and is from a highest quality peer-reviewed journal.
(suresh2026phosphoregulationofinterleukin1 pages 1-2): Manasa Suresh, Chrysilla Espy Vaz, Leona Dcunha, Rajesh Raju, Sneha M. Pinto, and Saptami Kanekar. Phosphoregulation of interleukin-1 receptor-associated kinase 1 in inflammatory signaling. Sep 2026. URL: https://doi.org/10.3389/fimmu.2026.1937314, doi:10.3389/fimmu.2026.1937314. This article has 0 citations and is from a peer-reviewed journal.
(pereira2022theirak4scaffold pages 3-5): Milton Pereira, Danielle F Durso, Clare E Bryant, Evelyn A Kurt-Jones, Neal Silverman, Douglas T Golenbock, and Ricardo T Gazzinelli. The irak4 scaffold integrates tlr4-driven trif and myd88 signaling pathways. Cell reports, 40:111225-111225, Aug 2022. URL: https://doi.org/10.1016/j.celrep.2022.111225, doi:10.1016/j.celrep.2022.111225. This article has 141 citations and is from a highest quality peer-reviewed journal.
(pereira2022theirak4scaffold pages 5-6): Milton Pereira, Danielle F Durso, Clare E Bryant, Evelyn A Kurt-Jones, Neal Silverman, Douglas T Golenbock, and Ricardo T Gazzinelli. The irak4 scaffold integrates tlr4-driven trif and myd88 signaling pathways. Cell reports, 40:111225-111225, Aug 2022. URL: https://doi.org/10.1016/j.celrep.2022.111225, doi:10.1016/j.celrep.2022.111225. This article has 141 citations and is from a highest quality peer-reviewed journal.
(li2023anoncanonicalirak4irak1 pages 3-4): Yuanyuan Li, Richa B. Shah, Samanta Sarti, Alicia L. Belcher, Brian J. Lee, Andrej Gorbatenko, Francesca Nemati, Honglin Yu, Zoe Stanley, Mahbuba Rahman, Zhengping Shao, Jose M. Silva, Shan Zha, and Samuel Sidi. A noncanonical irak4-irak1 pathway counters dna damage–induced apoptosis independently of tlr/il-1r signaling. Science Signaling, Dec 2023. URL: https://doi.org/10.1126/scisignal.adh3449, doi:10.1126/scisignal.adh3449. This article has 18 citations and is from a domain leading peer-reviewed journal.
(li2023anoncanonicalirak4irak1 pages 4-6): Yuanyuan Li, Richa B. Shah, Samanta Sarti, Alicia L. Belcher, Brian J. Lee, Andrej Gorbatenko, Francesca Nemati, Honglin Yu, Zoe Stanley, Mahbuba Rahman, Zhengping Shao, Jose M. Silva, Shan Zha, and Samuel Sidi. A noncanonical irak4-irak1 pathway counters dna damage–induced apoptosis independently of tlr/il-1r signaling. Science Signaling, Dec 2023. URL: https://doi.org/10.1126/scisignal.adh3449, doi:10.1126/scisignal.adh3449. This article has 18 citations and is from a domain leading peer-reviewed journal.
(pereira2023regulationofinnate pages 7-8): Milton Pereira and Ricardo T. Gazzinelli. Regulation of innate immune signaling by irak proteins. Frontiers in Immunology, Feb 2023. URL: https://doi.org/10.3389/fimmu.2023.1133354, doi:10.3389/fimmu.2023.1133354. This article has 164 citations and is from a peer-reviewed journal.
(pereira2022theirak4scaffold pages 6-8): Milton Pereira, Danielle F Durso, Clare E Bryant, Evelyn A Kurt-Jones, Neal Silverman, Douglas T Golenbock, and Ricardo T Gazzinelli. The irak4 scaffold integrates tlr4-driven trif and myd88 signaling pathways. Cell reports, 40:111225-111225, Aug 2022. URL: https://doi.org/10.1016/j.celrep.2022.111225, doi:10.1016/j.celrep.2022.111225. This article has 141 citations and is from a highest quality peer-reviewed journal.
(pereira2022theirak4scaffold pages 10-11): Milton Pereira, Danielle F Durso, Clare E Bryant, Evelyn A Kurt-Jones, Neal Silverman, Douglas T Golenbock, and Ricardo T Gazzinelli. The irak4 scaffold integrates tlr4-driven trif and myd88 signaling pathways. Cell reports, 40:111225-111225, Aug 2022. URL: https://doi.org/10.1016/j.celrep.2022.111225, doi:10.1016/j.celrep.2022.111225. This article has 141 citations and is from a highest quality peer-reviewed journal.
(pereira2022theirak4scaffold pages 8-10): Milton Pereira, Danielle F Durso, Clare E Bryant, Evelyn A Kurt-Jones, Neal Silverman, Douglas T Golenbock, and Ricardo T Gazzinelli. The irak4 scaffold integrates tlr4-driven trif and myd88 signaling pathways. Cell reports, 40:111225-111225, Aug 2022. URL: https://doi.org/10.1016/j.celrep.2022.111225, doi:10.1016/j.celrep.2022.111225. This article has 141 citations and is from a highest quality peer-reviewed journal.
(val2025humanirakkinases pages 7-9): Elba del Val, Giulia Genna, Teresa Fernández-Acero, María Molina, and Víctor J. Cid. Human irak kinases differentially alter metabolic regulation and mitochondrial function in saccharomyces cerevisiae. BioRxiv, Aug 2025. URL: https://doi.org/10.1101/2025.08.06.668917, doi:10.1101/2025.08.06.668917. This article has 0 citations.
(pereira2023regulationofinnate pages 6-7): Milton Pereira and Ricardo T. Gazzinelli. Regulation of innate immune signaling by irak proteins. Frontiers in Immunology, Feb 2023. URL: https://doi.org/10.3389/fimmu.2023.1133354, doi:10.3389/fimmu.2023.1133354. This article has 164 citations and is from a peer-reviewed journal.
(pereira2022theirak4scaffold pages 18-19): Milton Pereira, Danielle F Durso, Clare E Bryant, Evelyn A Kurt-Jones, Neal Silverman, Douglas T Golenbock, and Ricardo T Gazzinelli. The irak4 scaffold integrates tlr4-driven trif and myd88 signaling pathways. Cell reports, 40:111225-111225, Aug 2022. URL: https://doi.org/10.1016/j.celrep.2022.111225, doi:10.1016/j.celrep.2022.111225. This article has 141 citations and is from a highest quality peer-reviewed journal.